4 results for "Rob Hagendijk"
Showing 1–4 · 1.14 seconds · RSS
-
Journal Article
Constructing a single market for pharmaceuticals in the EU: what’s the price?
The European Union (EU) is currently overhauling its pharmaceutical regulations, seeking to mature a single market for medicines as part of a ‘European Health Union’. We reflect on the interactions between regulations and markets in these reforms and investigate what this single market for…
-
Journal Article
How social pharmaceutical innovations are addressing problems of availability, accessibility and affordability of drugs for rare diseases
Abstract Background The current organization of the pharmaceutical innovation system poses three major challenges for rare disease patients in terms of availability, accessibility and affordability of treatments. While some changes have emerged in the European Union to address some of these…
-
Journal Article
Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases
Abstract Rare diseases are associated with difficulties in addressing unmet medical needs, lack of access to treatment, high prices, evidentiary mismatch, equity, etc. While challenges facing the development of drugs for rare diseases are experienced differently globally (i.e., higher vs. lower and…